Gender and Psychiatry: Pathologized Emotions

As Phyllis Chesler warned us in 1974, gender bias has accompanied psychiatric power throughout its history. Years later, in 2005, in the last annotated edition of Women and Madness , the author insisted on the persistence of this bias, which even today, 50 years later, seems to remain unchanged. Authors such as Ussher, Caplan, Margot Pujal and many others were situated in that same space. With their differences and nuances, they all converge on the same point: gender problems and discomforts produce deep suffering. This suffering leaves marks on our bodies and our behavior.

Gender and Psychiatry: Pathologized Emotions

Be Careful What You Say

How honesty leads to the trauma of unnecessary psychiatric hospitalization

Picture a soul in turmoil, wrapped in the suffocating embrace of despair. In the sanctuary of a therapist’s office, they finally find the courage to voice the unspeakable: 

“Sometimes, I think about not being here anymore.” 

The words hang heavy in the air, a testament to the crushing weight of their pain, loneliness, and emptiness. This confession, born from a place of vulnerability and trust, should be the beginning of a deeper healing journey.

During these intense emotional struggles, it’s important to understand that thoughts of escape, including suicide, are a common human response to overwhelming pain. There’s a vast chasm between contemplating an end to suffering and actively planning to end one’s life.

Be Careful What You Say

Placebo effect for all psychiatric diagnoses “of considerable magnitude”

In a new study, researchers found huge improvements in psychiatric symptoms on placebo alone, particularly for depression and anxiety. They included the 10 least biased, most recent randomised controlled trials for nine common diagnoses in their attempt to quantify the improvements that could be expected without treatment.

Placebo effect for all psychiatric diagnoses “of considerable magnitude” (archived)

Marx, Spinoza, and the Political Implications of Contemporary Psychiatry

Simple logic tells us that those atop a societal hierarchy will provide rewards for professionals—be they clergy or psychiatrists—who promote an ideology that maintains the status quo, and that the ruling class will do everything possible to manipulate the public to believe that the social-economic-political status quo is natural.

Marx, Spinoza, and the Political Implications of Contemporary Psychiatry

Millions of Dollars of Pharma Money Went to the DSM-5-TR Authors

Source: Talk World Radio: Bruce Levine on Psychiatry and Spinoza

About 60% of the authors had financial ties to industry, which are not disclosed in the DSM. Studies show that conflicts of interest lead to pro-industry decision-making.

Millions of Dollars of Pharma Money Went to the DSM-5-TR Authors

H/T: Unorthodox Truth

Previously:

Scientific Misconduct and Fraud: The Final Nail in Psychiatry’s Antidepressant Coffin

Scientific Misconduct and Fraud: The Final Nail in Psychiatry’s Antidepressant Coffin

“. . . if the major media picks up on this story, they will have the chance to report on what arguably is the worst—and most harmful—scandal in American medical history”

Robert Whitaker, publisher of madinamerica.com, January 3, 2024

Historically, there have always been some patients who report that any treatment for depression—including bloodletting—has worked for them, but science demands that for a treatment to be deemed truly effective, it must work better than a placebo or the passage of time without any treatment. This is especially important for antidepressant drugs—including Prozac, Zoloft, and other selective serotonin reuptake inhibitors (SSRIs), as well as Effexor, Cymbalta, and other serotonin and norepinephrine reuptake inhibitors (SNRIs)—because all of these drugs have uncontroversial troubling side effects.

Scientific Misconduct and Fraud: The Final Nail in Psychiatry’s Antidepressant Coffin

Related:

Once Radical Critiques of Psychiatry are Now Mainstream, So What Remains Taboo?

Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here’s What’s Next